Startups
Elix, Inc. is an AI drug discovery company with the mission of “Rethinking Drug Discovery.” In addition to talented AI researchers and engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. Elix is professionally and culturally diverse, with members coming from more than 10 different countries. Since Elixʼs foundation, English has been the official language of our team in anticipation of global expansion.
Overview
Location
Japan, Tokyo
Employees
11-50
Founded date
2016
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 2, 2025 | Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery | elix_tohokuuniversity-logo TOKYO, JAPAN, October 2, 2025 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) and the Graduate School of Life Sciences at Tohoku University (Dean: Kouki Hikosaka / Hea... |
| Apr 15, 2025 | The Future of Drug Development: A New Era of Innovation and Collaboration | In the world of pharmaceuticals, innovation is the lifeblood. The landscape is shifting, driven by collaboration and cutting-edge technology. Two recent developments illustrate this trend: the European Commission's impending decision on lec... |
| Apr 14, 2025 | PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets | Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform TOKYO, April 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM BioLab&... |
| Oct 10, 2023 | Elix、新機能が搭載されたAI 創薬プラットフォーム「Elix Discovery™」のカスタマイズ提供とトライアルを開始 | 「創薬を再考する」をミッションとしたAI創薬企業の株式会社Elix（代表取締役： 結城 伸哉 （ゆうき しんや）/ 本社：東京都千代田区、以下「Elix」または「当社」）は、新機能が搭載されたAI 創薬プラットフォーム「Elix Discovery™」のカスタマイズ提供とトライアルを開始しました。 Elix Discovery™は、化合物プロファイル予測・構造生成が可能で、ケミストが直感的に使用できるAI創薬のためのソフトウェアプラットフォームです。昨年6月にElix Di... |
| Oct 31, 2022 | AI Drug Discovery Company Elix Commences Joint Research With Proprietary Screening Technology Holder SEEDSUPPLY | Elix, and SEEDSUPPLY Inc. hereby announce the start of joint research. Latest Aithority Insights : Adobe Target Announces New AI-enriched Enhancements for Multi-channel Personalization SEEDSUPPLY proposes an agile drug discovery process for... |
Reviews 0
FAQ about Elix, Inc.
When was Elix, Inc. founded?
Elix, Inc. was founded in 2016.
What has the press written about Elix, Inc.?
Parsers VC has collected 6 articles mentioning Elix, Inc., among them “Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery” (Oct 2, 2025) and “The Future of Drug Development: A New Era of Innovation and Collaboration” (Apr 15, 2025).
Is Elix, Inc. still active?
Yes, Elix, Inc. is active; its latest activity on Parsers VC dates from Jul 29, 2026.